We are live on ! Find out more
SCM

Smead Capital Management Portfolio holdings

AUM $4.6B
1-Year Est. Return 27.56%
This Fund
S&P 500
This Quarter Est. Return
+4.46%
1 Year Est. Return
+27.56%
3 Year Est. Return
+64.97%
5 Year Est. Return
+125.46%
10 Year Est. Return
+462.58%
AUM
$494M
AUM Growth
Cap. Flow
+$493M
Cap. Flow %
99.8%
Top 10 Hldgs %
50.43%
Holding
28
New
28
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
CAB
Cabela's Inc
CAB
+$31.3M
2
TGNA
TEGNA Inc
TGNA
+$28.2M
3
EBAY icon
eBay
EBAY
+$25.8M
4
WBA
Walgreens Boots Alliance
WBA
+$25.6M
5
AMGN icon
Amgen
AMGN
+$24.2M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 36.18%
2 Financials 25.51%
3 Consumer Discretionary 20.69%
4 Communication Services 11.21%
5 Technology 3.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABBV icon
26
AbbVie
ABBV
$465B
$9.14M 1.85%
+221,078
New +$9.67M
ABT icon
27
Abbott
ABT
$187B
$7.71M 1.56%
+221,091
New +$8.11M
USB icon
28
US Bancorp
USB
$97.9B
$996K 0.2%
+27,571
New +$946K

Similar funds

Smead Capital Management's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for Smead Capital Management, which disclosed 28 positions worth $494M. Its ten largest holdings account for 50% of the portfolio.

Its largest position is Cabela's Inc: 483,211 shares worth $31.3M.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, followed by Financials and Consumer Discretionary.

  • Smead Capital Management's largest Q2 2013 buy was Cabela's Inc: 483,211 shares worth $31.3M.
  • Smead Capital Management's ten largest holdings make up 50% of its $494M portfolio in Q2 2013.
  • Smead Capital Management disclosed 28 positions in Q2 2013, its first 13F filing on record.

Based on Smead Capital Management's 13F filing for Q2 2013, filed 8 Aug 2013.